Abeona Therapeutics (ABEO) Capital Expenditures (2011 - 2026)
Abeona Therapeutics' (ABEO) quarterly Capital Expenditures came in at $935000.0 in Q1 2026, up 2497.44% year-on-year from $35997.0 in Q1 2025, and up 115.24% quarter-over-quarter from -$6.1 million in Q4 2025.
Abeona Therapeutics (ABEO) Capital Expenditures (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Capital Expenditures history runs 15 years deep, the most recent figure standing at $935000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 2497.44% year-over-year to $935000.0 in Q1 2026; TTM through Mar 2026 was $1.7 million, a 275.56% increase from a year earlier, with the FY2025 full-year figure at $685000.0, up 478.45% from the prior year.
- Capital Expenditures rose to $935000.0 in Q1 2026 per ABEO's latest filing, from -$6.1 million in the prior quarter.
- Across five years, Capital Expenditures topped out at $5.5 million in Q3 2025 and bottomed at -$6.1 million in Q4 2025.
- The 5-year median for Capital Expenditures is $120500.0 (2022), against an average of $112687.5.
- Biggest YoY gain for Capital Expenditures was 7800.0% in 2024; the steepest drop was 1564.49% in 2024.
- Year by year, Capital Expenditures stood at $278000.0 in 2022, then sank by 50.36% to $138000.0 in 2023, then slumped by 1564.49% to -$2.0 million in 2024, then sank by 203.66% to -$6.1 million in 2025, then soared by 115.24% to $935000.0 in 2026.
- Per Business Quant, the three latest ABEO Capital Expenditures figures stand at $935000.0 (Q1 2026), -$6.1 million (Q4 2025), and $5.5 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Abeona Therapeutics | 107.85 Mn | -60.42 Mn | 6.02 Mn | 935,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 935,000.00 |
| Mar 31, 2026 | 935,000.00 |
| Dec 31, 2025 | -6.14 Mn |
| Dec 31, 2025 | -6.14 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Sep 30, 2025 | 5.46 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Dec 31, 2024 | -2.02 Mn |
| Dec 31, 2024 | -2.02 Mn |
| Sep 30, 2024 | 404,000.00 |
| Sep 30, 2024 | 404,000.00 |
| Jun 30, 2024 | 711,000.00 |
| Jun 30, 2024 | 711,000.00 |
| Mar 31, 2024 | 725,000.00 |
| Mar 31, 2024 | 725,000.00 |
| Dec 31, 2023 | 138,000.00 |
| Dec 31, 2023 | 138,000.00 |